UHS (UHS) director Elliot Sussman granted 1,217 restricted stock units in equity award

Q: What did UHS director Elliot J. Sussman receive in this Form 4 filing?

Elliot J. Sussman received 1,217 restricted stock units of Universal Health Services Class B Common Stock. These units were granted as equity compensation under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan.

Q: How many UHS shares does Elliot J. Sussman hold after this RSU grant?

Following the grant, Elliot J. Sussman directly holds 7,330 shares of Universal Health Services Class B Common Stock. This figure reflects his position after the 1,217 restricted stock units were added in this reported transaction.

Q: What plan governs the UHS restricted stock units granted to Elliot J. Sussman?

The restricted stock units were granted under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan . This plan provides for stock-based incentives such as restricted stock units for directors and other eligible participants.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

SUSSMAN ELLIOT J MD MBA reported acquisition or exercise transactions in this Form 4 filing.

Universal Health Services director Elliot J. Sussman received an equity grant in the form of restricted stock units of the company’s Class B Common Stock. He was awarded 1,217 restricted stock units, which increased his direct holdings to 7,330 shares after the transaction.

The grant was made at no cash cost to Sussman and was issued under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units are scheduled to vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that occurs at least 50 weeks after the 2026 annual meeting date of May 20, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SUSSMAN ELLIOT J MD MBA

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class B Common Stock	1,217	$0.00	--

Holdings After Transaction: Class B Common Stock — 7,330 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 1,217 restricted stock units Holdings after grant: 7,330 shares Grant price per share: $0.0000 per share +2 more

5 metrics

RSU grant size 1,217 restricted stock units Award of Class B Common Stock units on May 20, 2026

Holdings after grant 7,330 shares Total direct Class B Common Stock after transaction

Grant price per share $0.0000 per share Equity compensation, no cash paid by director

Latest vesting date May 20, 2027 All RSUs vest by this date at the latest

Meeting-based vest trigger At least 50 weeks Next annual meeting must be 50+ weeks after May 20, 2026

Key Terms

restricted stock units, Amended and Restated 2020 Omnibus Stock and Incentive Plan, vest, annual meeting of stockholders

4 terms

restricted stock units financial

"The restricted stock units were granted pursuant to the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Amended and Restated 2020 Omnibus Stock and Incentive Plan financial

"granted pursuant to the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan"

vest financial

"all units shall vest on the earlier of May 20, 2027 or the next annual meeting of stockholders"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"the earlier of May 20, 2027 or the next annual meeting of stockholders which is at least 50 weeks after the 2026 annual meeting date of May 20, 2026"

Form 4 Insider Transactions: What Each Field Means →

05/21/2026 - 04:26 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SUSSMAN ELLIOT J MD MBA

(Last)

(First)

(Middle)

2365 BAYPOINT WAY

(Street)

THE VILLAGES

FLORIDA

32162

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL HEALTH SERVICES INC [ UHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	05/20/2026		A⁽¹⁾		1,217	A	$0	7,330	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The restricted stock units were granted pursuant to the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan and all units shall vest on the earlier of May 20, 2027 or the next annual meeting of stockholders which is at least 50 weeks after the 2026 annual meeting date of May 20, 2026.

	/s/ Steve Filton, attorney-in-fact for Dr. Sussman	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did UHS director Elliot J. Sussman receive in this Form 4 filing?

Elliot J. Sussman received 1,217 restricted stock units of Universal Health Services Class B Common Stock. These units were granted as equity compensation under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan.

How many UHS shares does Elliot J. Sussman hold after this RSU grant?

Following the grant, Elliot J. Sussman directly holds 7,330 shares of Universal Health Services Class B Common Stock. This figure reflects his position after the 1,217 restricted stock units were added in this reported transaction.

When do Elliot J. Sussman’s newly granted UHS restricted stock units vest?

All of Sussman’s newly granted restricted stock units vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that occurs at least 50 weeks after the May 20, 2026 annual meeting.

What plan governs the UHS restricted stock units granted to Elliot J. Sussman?

The restricted stock units were granted under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan. This plan provides for stock-based incentives such as restricted stock units for directors and other eligible participants.

Did Elliot J. Sussman pay cash for the UHS restricted stock units granted?

No cash changed hands for this transaction; the Form 4 shows a $0.0000 transaction price per share. The 1,217 restricted stock units were granted as equity compensation rather than purchased in the open market.